Glidax-PM 2 is formulated for patients whose blood sugar levels remain high despite dual-drug therapy. This “Triple Action” medication targets diabetes through three different mechanisms:
-
Glimepiride (2mg): A sulfonylurea that triggers the pancreas to release more insulin.
-
Pioglitazone: A sensitizer that helps the body’s cells use insulin more effectively and reduces insulin resistance.
-
Metformin (ER): Reduces the amount of sugar produced by the liver. The Extended Release (ER) technology ensures a steady delivery of medicine throughout the day, significantly reducing common digestive side effects.
Together, these ingredients work synergistically to lower HbA1c levels, prevent post-meal sugar spikes, and protect against long-term diabetic complications such as kidney disease and nerve damage.
Key Benefits
-
Triple-Pathway Control: Manages glucose production, insulin secretion, and insulin sensitivity.
-
Higher Glimepiride Strength: 2mg dose for more effective insulin stimulation.
-
Sustained Glucose Stability: Metformin ER provides steady 24-hour glycemic management.
-
Improved Compliance: Combines three medications into a single tablet.
-
Trusted Quality: High pharmaceutical standards from DH.
Directions for Use
-
Take this medicine exactly as prescribed by your doctor.
-
Usually taken once daily with the first main meal of the day.
-
Swallow the tablet whole with water.
-
Important: Do not crush, chew, or break the tablet, as it will destroy the Extended Release (ER) property.
Safety & Precautions
-
Rx Only: A valid medical prescription is mandatory.
-
Hypoglycemia Alert: This combination can cause low blood sugar. Always keep a quick sugar source (like juice or glucose tablets) nearby.
-
Inform your doctor if you have heart failure, liver disease, or a history of bladder issues.
-
Avoid alcohol as it can increase the risk of lactic acidosis.
-
Regular blood sugar and organ function monitoring is recommended.
Storage
-
Store in a cool, dry place.
-
Protect from direct sunlight and moisture.
-
Keep out of reach of children.
